Diseases, Conditions, Syndromes

Experts develop immune-enhancing therapies to target tuberculosis

Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease. ...

Medications

Treatment for deadly superbug C. diff may be weakening

The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research from the University of Houston ...

Medications

Study finds AI can develop treatments to prevent 'superbugs'

Cleveland Clinic researchers developed an artificial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on how quickly the ...

page 2 from 4